Bladder-Sparing Chemoradiotherapy Combined with Immune Checkpoint Inhibition for Locally Advanced Urothelial Bladder Cancer—A Review

SIMPLE SUMMARY: Immunotherapy with immune checkpoint inhibition (ICI) has provided durable treatment responses in advanced, metastatic, bladder cancer patients. The first trials using checkpoint inhibitors before surgery, when the cancer is still confined to the pelvis, without signs of metastasis,...

Descripción completa

Detalles Bibliográficos
Autores principales: van Hattum, Jons W., de Ruiter, Ben-Max, Oddens, Jorg R., Hulshof, Maarten C. C. M., de Reijke, Theo M., Bins, Adriaan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750609/
https://www.ncbi.nlm.nih.gov/pubmed/35008202
http://dx.doi.org/10.3390/cancers14010038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750609/
https://www.ncbi.nlm.nih.gov/pubmed/35008202
http://dx.doi.org/10.3390/cancers14010038

Ejemplares similares